Efficacy and safety of ipragliflozin in Japanese patients with type 2 diabetes receiving conventional therapy: clinical implication of the importance of exercise habits during treatment with ipragliflozin
Crossref DOI link: https://doi.org/10.1007/s13340-017-0307-1
Published Online: 2017-02-08
Published Print: 2017-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kato, Mitsutoshi
Sakai, Kumiko
Saito, Kyoko
Tsutsui, Kensuke
Yamashita, Shigeo
Kato, Noriko
Funding for this research was provided by:
Astellas Pharma
License valid from 2017-02-08